https://www.selleckchem.com/products/kppep-2d.html
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association between the development of adverse events (AEs) and IFX-TLs has not been sufficiently studied thus far. To investigate the possible association of IFX-TLs with AEs in Greek patients with IBD receiving maintenance treatment with IFX. A retrospective analysis of the registry data of the Gastroenterology Department of the University Hospital of Heraklion, from IBD patients wit
Like
Comment
Share
